Japanese Trademark — JPO

The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".

Application 2025362490 · 00

Quick Facts

Application Number	2025362490
Registration Number	1879241
Status	00
Mark (native)	The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".
Mark Type	madrid
Owner	Ionis Pharmaceuticals, Inc.
Filed	2025-10-09
Registered	2025-05-21

Is this trademark active?

The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A". has a current status of 00.

Goods & Services

The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.

Class 5 — Pharmaceuticals

Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceuticals in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders.

Class 35 — Advertising & Business

Collecting data and information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for treatment and diagnostic purposes.

Class 44 — Medical & Beauty Services

Medical services; medical information services; collecting data and information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for treatment and diagnostic purposes; medical consulting services in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders via a web site; providing medical and healthcare information concerning the screening, diagnosis, and treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders.

Applicant

Name (romanised)

Ionis Pharmaceuticals, Inc.

Timeline

Filed: 2025-10-09
Registered: 2025-05-21

About This Trademark

'The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".' is a 00 trademark on the Japan Patent Office register, owned by Ionis Pharmaceuticals, Inc.. The application (2025362490) was filed on 9 October 2025 and registered on 21 May 2025.

This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 44 (medical, veterinary & beauty services), specifically covering: Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceuticals in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders.; Collecting data and information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for treatment and diagnostic purposes.; Medical services; medical information services; collecting data and information on autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders for treatment and diagnostic purposes; medical consulting services in the field of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders; providing medical and healthcare information for healthcare professionals, caregivers, patients, and providers in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders via a web site; providing medical and healthcare information concerning the screening, diagnosis, and treatment of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and disorders.

Frequently Asked Questions

Who owns Japanese trademark 2025362490 ('The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".')?

Japanese trademark 2025362490 for the mark 'The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".' in Class 5, 35, 44 is recorded on the Japan Patent Office register as owned by Ionis Pharmaceuticals, Inc.. This covers one specific Japanese trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.

Is Japanese trademark 2025362490 currently a registered trademark?

No — the Japan Patent Office records the status of Japanese trademark 2025362490 for the mark 'The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".' as 00.

Which Nice classes is Japanese trademark 2025362490 registered under?

Japanese trademark 2025362490 for the mark 'The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 35 (advertising, business management & retail services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations and substances for the treatment of edema, namely hereditary angioedema; pharmaceuticals in the fields of autosomal dominant, autosomal recessive, genetic, edema, pulmonary, respiratory, ophthalmic, gastrointestinal, skin, autoimmune, lymphoproliferative, and rare diseases and di…

When was Japanese trademark 2025362490 filed?

Japanese trademark 2025362490 for the mark 'The mark consists of the word "DAWNZERA" to the left of a partial sunrise design over the letter "A".' was filed at the Japan Patent Office on 9 October 2025 and registered on 21 May 2025.

Data Source

Japan (Japan Patent Office)

Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-05-02.

The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.